APOLIPOPROTEIN A I

Primary DI

06975225462183

Basic UDI-DI Code

B-06975225462183

Reference

DTSH060508

Device Types

None provided

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Da Te Bioengineering Technology Co., LTD.

This kit is intended for in vitro quantitative detection of apolipoprotein A1 (ApoA1) in human serum. ApoA1 is the major structural protein of HDL, HDL represented by ApoA1 is negatively correlated with the prevalence of coronary heart disease. When using total cholesterol and triglycerides to screen out coronary heart disease, in addition to the detection of lipoprotein (a) and apolipoprotein B, simultaneously the detection of ApoA1 provide more information on lipid disorders, and also can replace high density lipoprotein cholesterol testing. In addition coronary heart disease patients have low ApoA1, cerebrovascular patients also. ApoA1 deficiency, family clusters of low α hyperlipoproteinemia, and fish eye disease patients have very low ApoA1. Family cluster of high TG in patients with hyperlipidemia have low HDL-C, but ApoA1 not necessarily low, do not increase the risk of coronary heart disease.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).